Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg L Plosker

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Drugs|February 19, 2014
Rivaroxaban: a review of its use in acute coronary syndromesGreg L Plosker
Pharmacoeconomics|October 13, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countriesGreg L Plosker
Pharmacoeconomics|August 16, 2011
Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal diseaseGreg L Plosker
Pharmacoeconomics|April 21, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countriesGreg L Plosker
Drugs|April 23, 2015
Memantine extended release (28 mg once daily): a review of its use in Alzheimer's diseaseGreg L Plosker
Paediatric Drugs|September 28, 2012
Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countriesGreg L Plosker
Drugs|February 28, 2013
Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxisGreg L Plosker
Drugs|November 20, 2008
Pegylated liposomal Doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myelomaGreg L Plosker
Paediatric Drugs|September 7, 2014
10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and childrenGreg L Plosker
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2009
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the USGreg L Plosker
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Drugs|February 19, 2014
Rivaroxaban: a review of its use in acute coronary syndromesGreg L Plosker
Pharmacoeconomics|October 13, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countriesGreg L Plosker
Pharmacoeconomics|August 16, 2011
Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal diseaseGreg L Plosker
Pharmacoeconomics|April 21, 2011
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countriesGreg L Plosker
Drugs|April 23, 2015
Memantine extended release (28 mg once daily): a review of its use in Alzheimer's diseaseGreg L Plosker
Paediatric Drugs|September 28, 2012
Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countriesGreg L Plosker
Drugs|February 28, 2013
Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxisGreg L Plosker
Drugs|November 20, 2008
Pegylated liposomal Doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myelomaGreg L Plosker
Paediatric Drugs|September 7, 2014
10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and childrenGreg L Plosker
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2009
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the USGreg L Plosker
Pageof 18